CEIPI launches a new Advanced Training Program on Regulatory Affairs and Intellectual Property Protection in the Pharmaceutical Industry, a unique educational proposal targeting regulatory and intellectual property professionals in the pharmaceutical sector. The three days of training revolve around the interface between patent law, supplementary protection certificates and test data protection.
This training program is addressed to regulatory officers, patent attorneys and in-house lawyers, as well as public servants working in public health organizations, who must navigate through the several legal domains of relevance in pharmaceutical research, development and innovation.
When it comes to pharmaceutical products, branches of law of administrative nature become tied to private law. The interfaces between pharmaceutical law, intellectual property law, competition law and consumer law are numerous. Patents, supplementary protection certificates and regulatory exclusivities, notably test data protection, make up a sophisticated legal framework of overlapping exclusivities that impact both on innovation and competition.
The program has a total duration of 20 hours, distributed in three days (Thursday 19 to Saturday 21 September 2019)
The program has been jointly designed and directed by
- Xavier Seuba, Associate Professor of Law, Academic Coordinator and Scientific Responsible of CEIPI. Director of the Diploma on Patent Litigation in Europe
- Peter Thomsen, Chairman of the Litigation Committee of the Institute of Professional Representatives before the European Patent Office
- Francis Ahner, Of Counsel, French Patent Attorney, European Patent Attorney, Life Sciences & Chemistry Department at Regimbeau
See all details and download the registration documents on the dedicated website
